AXIM BIOTECHNOLOGIES, INC. (AXIM) Operating margin 2015–2023
AXIM BIOTECHNOLOGIES, INC. (AXIM) operating margin by fiscal year — reported operating income divided by reported revenue.
-6961.0%FY2023 · since FY2015: -20451.3% → -6961.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | -6961.0% | +2646.1 pp |
| FY2022 | -9607.1% | +13507.4 pp |
| FY2021 | -23114.5% | — |
| FY2019 | -388.9% | +2185.7 pp |
| FY2018 | -2574.5% | +4045.0 pp |
| FY2017 | -6619.5% | +1369.3 pp |
| FY2016 | -7988.8% | +12462.4 pp |
| FY2015 | -20451.3% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More AXIM financial trends
AXIM RevenueAXIM Net incomeAXIM Net marginAXIM Gross profitAXIM Gross marginAXIM Operating incomeAXIM Operating cash flowAXIM Free cash flowAXIM Capital expendituresAXIM Return on equityAXIM Stock buybacksAXIM Dividends paidAXIM Total assetsAXIM Total liabilitiesAXIM Shareholders’ equityAXIM overview →